X4 Pharmaceuticals(XFOR) - 2024 Q4 - Annual Report
X4 Pharmaceuticals(XFOR)2025-03-25 22:16UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Exact name of registrant as specified in its charter) ________________________________________________________________________________________________________ Delaware (857) 529-8300 (Registrant's telephone number, including area code) (State or other jurisdiction of incorporation or organization) 61 North Beacon Street, 4th Floo ...